Skip to content

Natrelle Inspira SoftTouch Breast Implants TSF-415Recalls & reported problems

Allergan, Inc. · Natrelle Inspira TSF 415cc Full profile BIOCELL |textured|round|silicone · Class 3 · Implant

All models of Natrelle Breast Implants (1167) · Natrelle Inspira SoftTouch Breast Implants (195)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
8
Deaths reported
0
Injuries reported
8
Recalls naming it
1

Summary

The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 10888628034167), received between Mar 21, 2018 and Aug 18, 2026 — classified as 8 injuries.

The most frequently reported specific device problem is “Material Rupture” (5 reports).

1 FDA recall record name this device's identifier, 1 still open.

3 other recalls cover devices cleared under the same FDA submission (P020056); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 1 reportsJul 2026: 1 reportsAug 2026: 1 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Jul 24, 2019Class IOpen, Classified

    The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.

    Z-2453-2019 · Root cause: Unknown/Undetermined by firm · Recall details · FDA record ↗

Most reported problems

Device problems

  • Material Rupture5
  • Device Appears to Trigger Rejection2
  • Insufficient Device Problem Information1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3
  • Capsular Contracture2
  • Failure of Implant2
  • Hematoma1
  • Hemorrhage/Blood Loss/Bleeding1
  • Seroma1

Recent adverse event reports

The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 18, 2026Material Rupture

    Healthcare professional reported ¿Rupture¿. This record is for the right side. Device was explanted.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50302721 ↗
  • InjuryJul 27, 2026Material Rupture

    Patient reported "no complaint against the device". Patient later reported "implant remains intact with small number of radial folds, small cysts". Healthcare professional later reported "ruptured, foreign body giant cell reaction, chronic inflammation, synovial metaplasia and nerve bundle proliferation". This record is for the left side. The device has been explanted.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50038082 ↗
  • InjuryJun 5, 2026Material Rupture

    HEALTHCARE PROFESSIONAL REPORTED "CAPSULE RUPTURE", "FREE FLUID BETWEEN INTERNAL QUADRANTS" AND "RUPTURE OF CAPSULE". THIS RECORD IS FOR THE RIGHT SIDE. DEVICE REMAINS IMPLANTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25408784 ↗
  • InjuryAug 26, 2024Material Rupture; Material Rupture

    PATIENT REPORTED "SHE IS SCARED TO DEATH AND WANTS THEM OUT. SHE HAS ALREADY HAD NON-HODGKIN'S LYMPHOMA - NOT RELATED TO THE DEVICE AND SWELLING IN THE RIGHT BREAST". PATIENT LATER REPORTED "RUPTURE VIA MRI AND MAMMOGRAM, PAIN, DRASTICALLY DEFORMED, AND ONE SIDE HEADED UP TO THE SHOULDER AND OTHER HANGING DOWN WAIST". HEALTHCARE PROFESSIONAL LATER REPORTED RUPTURE AND EXCHANGE FROM TEXTURED TO SMOOTH DUE TO THE CONCERNS OF THE PRODUCT. THIS RECORD IS FOR THE RIGHT SIDE. THE DEVICE REMAINS IMPLANTED.

    Patient problems: Failure of Implant

    MAUDE report 20065384 ↗
  • InjuryMar 10, 2023Material Rupture; Material Rupture

    HEALTHCARE PROFESSIONAL REPORTED, A "RIGHT SIDE RUPTURE". DEVICE HAS BEEN EXPLANTED AND REPLACED.

    Patient problems: Failure of Implant

    MAUDE report 16527135 ↗
  • InjuryMar 10, 2023Device Appears to Trigger Rejection; Device Appears to Trigger Rejection

    HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE CAPSULAR CONTRACTURE BAKER GRADE III. DEVICE WAS EXPLANTED.

    Patient problems: Capsular Contracture

    MAUDE report 16526670 ↗
  • InjuryJun 14, 2021Device Appears to Trigger Rejection; Device Appears to Trigger Rejection

    HEALTHCARE PROFESSIONAL REPORTED EXCHANGE FROM TEXTURED TO SMOOTH BREAST IMPLANTS DUE TO THE PATIENT¿S CONCERN WITH THE PRODUCT, "FLUID ON THE IMPLANT," AND CAPSULAR CONTRACTURE, BAKER GRADE III. THE DEVICE REMAINS IMPLANTED. THIS RECORD IS FOR THE RIGHT SIDE.

    Patient problems: Capsular Contracture; Seroma

    MAUDE report 11992148 ↗
  • InjuryMar 21, 2018Insufficient Device Problem Information; Insufficient Device Problem Information

    REPORTED EVENTS OF RIGHT SIDE ¿FLUID ACCUMULATION,¿ AND ¿SUBACUTE HEMATOMA¿ FOR A PATIENT IMPLANTED WITH A ¿ROUND SILICONE¿ ALLERGAN TSF DEVICE WERE NOTED IN ¿SUBACUTE ARTERIAL BLEEDING AFTER SIMULTANEOUS MASTOPEXY AND BREAST AUGMENTATION WITH IMPLANTS: CASE REPORT." DURING REVISION SURGERY, ¿A BLOOD CLOT OF 650 ML WAS REMOVED,¿ AND ¿BLEEDING FROM ONE OF THE INTERNAL MAMMARY ARTERY BRANCHES IN THE IMPLANT POCKET BETWEEN THE RIB CAGE AND PECTORAL MUSCLE LOWER POLE WAS DETECTED AND STOPPED.¿ TREATMENT OF ¿VACUUM DRAINAGE¿ WAS ADDITIONALLY PROVIDED, AND THE DEVICE REMAINS IMPLANTED.

    Patient problems: Hematoma; Hemorrhage/Blood Loss/Bleeding

    MAUDE report 7357784 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P020056. One submission often covers many models, so check the product and lot details in each record.

  • Z-0701-2020 · Nov 6, 2019 · Terminated
    Natrelle Inspira Sillicone-Filled Breast Implants for the following Styles and Sizes: 7607 SSM, 7608 SSF, 7609 SSX, 7513 SRL, 7514 SRLP, 7515 SRM, 7516 SRF, 7517 SRX, 7626 SCL, 762
  • Z-0700-2020 · Nov 6, 2019 · Terminated
    Natrelle Silicone Filled Breast Implants for the following Styles and Sizes: Style 10, Style 15, Style 20, Style 40, Style 45 Style 10/UDI: NATRELLE Style 10-180 Gel Round Mod
  • Z-2454-2019 · Jul 24, 2019 · Open, Classified
    Natrelle and McGhan Silicone-Filled Breast Implant BioCell Round Moderate Profile, Sterile, for the following style numbers: Style 110:110-090, 110-120, 110-150, 110-180, 110-

Other Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled devices

All Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page